News
Three important pieces of health-related legislation that were endorsed and supported by the Masonic Cancer Center were passed by the Minnesota House and Senate
Three important pieces of health-related legislation that were endorsed and supported by the Masonic Cancer Center were passed by the Minnesota House and Senate before the end of the current session, with one of them being signed into law…
University of Minnesota Researchers Study Radiation Resistance in Brain Cancer Cells
Author: Kelly Glynn, Media Relations Coordinator
In a vertical climb to avoid collision with a towering mountain, a plane ejects cargo to gain altitude. Investigators at the University of Minnesota showed that cancer cells perform…
Dr. Robert Clarke named new Executive Director to lead The Hormel Institute, University of Minnesota
6th director comes from Georgetown UniversityDr. Robert Clarke of Georgetown University in Washington, D.C., has been named the next executive director of The Hormel Institute, University of Minnesota.
Hormel Institute scientist finds breakthrough for liver cancer promotion
New research sheds light on metastatic cancer in the liver
Dr.Ningling Kang, head of the Tumor Microenvironment and Metastasis lab at The Hormel Institute UMN, published a discovery describing how a particular protein, diaphanous homolog…
UMN’s Gordon and Odde receive a NCI grant to study how the brain protects leukemia cells from chemotherapy
University of Minnesota’s Gordon and Odde receive a National Cancer Institute (NCI) grant to study how the brain protects leukemia cells from the effects of chemotherapy
Masonic Cancer Center announces the appointment of Drs. Poynter and Harki to leadership roles
Jenny Poynter, MPH, PhD, and Daniel Harki, PhD, have been appointed to the leadership team of the Twin Cities’ only National Cancer Institute (NCI) designated comprehensive cancer center.
Susceptibility and Risk of COVID-19 for Cancer Patients
The past several months as COVID-19 has spread have been a scary time not only for the United States but the entire world. It is particularly frightening for those most greatly affected by COVID-10: people with underlying health conditions…
U of M opens first in class triple gene edited NK cell trial for treatment of patients with advanced B cell lymphoma
The University of Minnesota has pioneered the development of promising cell-based cancer immunotherapy called FT596, and today announced opening Phase 1 clinical trial using FT596 for treatment of Relapsed/refractory B cell lymphoma and…
UMN Institute scientist links ancient virus to cancer risk
Study of chromosome abnormalities reveals link to cancer(Austin, Minnesota) – The Hormel Institute, University of Minnesota announces newly published research concerning remnants of ancient viruses found in human chromosomes and how this…